Bulletin
Investor Alert

New York Markets After Hours

Reata Pharmaceuticals Inc. Cl A

NAS: RETA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209330283/composite

$

94.12

Change

+0.29 +0.31%

Volume

Volume 1,464

Sep 25, 2020, 4:59 p.m.

Real time quotes

/zigman2/quotes/209330283/composite

Today's close

$ 102.74

$ 93.83

Change

-8.91 -8.67%

Day low

Day high

$92.00

$103.46

Open
Open: 102.90

52 week low

52 week high

$73.38

$257.97

Open

Market cap

$3.45B

Average volume

355,777

P/E ratio

N/A

Rev. per Employee

$435,683

EPS

-10.73

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/reta

MarketWatch News on RETA

  1. Reata Pharmaceuticals stock price target raised to $290 from $275 at Ladenburg Thalmann

    8:37 a.m. Feb. 14, 2020

    - Tomi Kilgore

  2. Reata Pharma kidney drug meets study goals, stock halted

    5:23 p.m. Nov. 11, 2019

    - Wallace Witkowski

  3. Reata Pharmaceuticals stock price target raised to $210 from $135 at Stifel Nicolaus

    8:19 a.m. Oct. 16, 2019

    - Tomi Kilgore

  4. Reata Pharma stock halted after hours at $100.59

    4:03 p.m. Oct. 14, 2019

    - Wallace Witkowski

  5. Reata Pharmaceuticals stock price target raised to $180 from $139 at SVB Leerink

    7:22 a.m. Oct. 14, 2019

    - Tomi Kilgore

  6. Hedge Funds’ Health-Care Picks and Pans

    12:56 p.m. May 16, 2019

    - Barron's Online

  7. Freestone Capital Management Settles With Owens Realty Mortgage

    11:55 p.m. Jan. 5, 2018

    - Barron's Online

  8. Reata Pharmaceuticals started at outperform with $43 stock price target at Leerink

    6:53 a.m. Sept. 13, 2017

    - Tomi Kilgore

  9. Reata Pharmaceuticals started at buy with $38 stock price target at Stifel Nicolaus

    9:50 a.m. Feb. 23, 2017

    - Tomi Kilgore

  10. Reata Pharmaceuticals started at overweight with $33 stock price target at Piper Jaffray

    1:22 p.m. June 20, 2016

    - Tomi Kilgore

  11. Reata Pharmaceuticals shares surge 11% in trading debut

    12:05 p.m. May 26, 2016

    - Ciara Linnane

Analyst Ratings

/news/nonmarketwatch/company/us/reta

Other News on RETA

  1. Reata Pharmaceuticals Can Rally

    4:01 p.m. Sept. 21, 2020

    - Seeking Alpha

  2. Reata (RETA) Q2 Earnings Top, Omaveloxolone Setback Hurts

    11:26 a.m. Aug. 11, 2020

    - Zacks.com

  3. OMER, TRVN, KODK and NAVB among midday movers

    12:45 p.m. Aug. 10, 2020

    - Seeking Alpha

  4. 10-Q: REATA PHARMACEUTICALS INC

    7:00 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. Reata Pharmaceuticals Q2 Earnings Preview

    12:34 p.m. Aug. 9, 2020

    - Seeking Alpha

  6. Biotech Stock Q2 Earnings on Aug 10: NVAX, ICPT & More

    11:02 a.m. Aug. 7, 2020

    - Zacks.com

  7. NYU launches study of Reata's bardoxolone in COVID-19

    9:33 a.m. July 28, 2020

    - Seeking Alpha

  8. CLDX, NK, GRPN and MITT among midday movers

    12:41 p.m. June 11, 2020

    - Seeking Alpha

  9. HEXO, SRNE among premarket gainers

    9:12 a.m. June 11, 2020

    - Seeking Alpha

  10. Reata secures $350M investment to advance bardoxolone

    8:12 a.m. June 11, 2020

    - Seeking Alpha

  11. Reata (RETA) Q1 Earnings Surpass Estimates, Revenues Miss

    10:45 a.m. May 12, 2020

    - Zacks.com

  12. Loading more headlines...
/news/pressrelease/company/us/reta

Press Releases on RETA

  1. CNS Pharmaceuticals Announces US Drug Manufacturing Milestones

    8:03 a.m. Sept. 3, 2020

    - GlobeNewswire

  2. USA Bollinger Band Signals Bullish Stocks: $RETA $AWI $CNNE

    7:09 a.m. Sept. 3, 2020

    - The Market Signal

  3. Nrf2 Pathway Activators Market Global Research Report 2020 to 2026

    3:37 a.m. Aug. 25, 2020

    - Market Insight Reports

  4. CNS Pharmaceuticals Engages CRO For Phase 2 Berubicin Clinical Trials

    8:16 a.m. Aug. 20, 2020

    - Financial News Media

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.